AX-2026-041456
Humanin (HNG) · 10 mg declared · ChinaPeptides Co., Ltd. (QYAOBIO) · lot QYB-2512-A4980
- Report ID
- AX-2026-041456
- Compound
- Humanin (HNG)
- Compound class
- Metabolic and mitochondrial peptides
- Supplier
- QYB — ChinaPeptides Co., Ltd. (QYAOBIO)
- Batch / lot
- QYB-2512-A4980
- Declared label claim
- 10mg
- Laboratory
- Janoshik Analytical
- Assay date
- 19 Jan 2026
- Submitted
- 30 Jan 2026
- Quarter
- 2026-Q1
- Submitter
- nitrogen_kjeldahl
- Sample provenance
- Buyer-sourced
Results
Measured against the index acceptance specification for the metabolic and mitochondrial peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 30 min gradient, 214 nm | 99.60 | % area | ≥ 97.5 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 0.40 | % area | ≤ 2.5 | PASS |
| Largest single impurity | RP-HPLC — deamidated (+1 Da) | 0.27 | % area | ≤ 1.00 | PASS |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 2685.3153 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, high resolution (ESI-TOF/QTOF) | 2685.3148 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | -0.2 | ppm | ± 15 | PASS |
| Total peptide content | by difference from the gravimetric mass balance | 88.57 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 88.22 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 11.14 | mg | 10 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 9.828 | mg | 10 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 98.3 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 4.01 | % | ≤ 9.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 7.01 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.41 | % | — | NOT TESTED |
| Endotoxin | not ordered on this submission | not determined | — | ≤ 5.0 | NOT TESTED |
| Sterility | not ordered on this submission | not determined | — | no growth | NOT TESTED |
| Appearance | visual, diffuse light, black and white background | Off-white lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear with a single visible fibre | — | clear, no visible particulates | FAIL |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 3.62 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 30 min gradient | 12.04 | min | 12.14 ± 0.30 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.17 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 86,406 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs wild-type humanin (Ser14, −42 Da) | 0.89 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | Humanin (HNG) — main peak | 12.04 | 4,840,869 | 99.60 | — |
| 2 | deamidated (+1 Da) | 11.76 | 13,123 | 0.27 | +0.984 |
| 3 | Met sulfoxide (+16 Da) | 11.62 | 4,374 | 0.09 | +15.995 |
| 4 | truncated (1-20) | 10.69 | 972 | 0.02 | -472.245 |
| 5 | wild-type humanin (Ser14, −42 Da) | 11.89 | 972 | 0.02 | -42.011 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 2685.3153 Da, computed from C119H182N30O32S. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 5+ | 538.0703 | 538.0702 | -0.0001 | 9.1 |
| 4+ | 672.3361 | 672.3360 | -0.0001 | 53.5 |
| 3+ | 896.1124 | 896.1122 | -0.0002 | 100.0 |
| 2+ | 1343.6649 | 1343.6647 | -0.0002 | 57.1 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 4.01 |
| Counter-ion (acetate) | ion chromatography | 7.01 |
| Residual solvent + inorganic residue | estimated | 0.41 |
| Total peptide content | by difference | 88.57 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 98.67 | 99.60 | divergence -0.60 pp vs batch median |
| Total impurities (% area) | 1.33 | 0.40 | |
| Largest single impurity (% area) | not stated | 0.27 | |
| Water (%) | 4.1 | 4.01 | |
| Counter-ion (%) | not stated | 7.01 | |
| Peptide content (%w/w) | not stated | 88.57 | |
| Endotoxin (EU/mg) | not stated | not determined | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Buyer-sourced
- Evidentiary weight
- Strongest available evidence in this index.
- Chain of custody
- Retail purchase → submitter (2–8 °C, 16 d) → laboratory (courier, ambient, 8 d) → assay.
- Assay date
- 19 Jan 2026
- Submitted to the index
- 30 Jan 2026
- Laboratory
- Janoshik Analytical, Ostrava, Czechia
- Method basis
- 30 min gradient · high-resolution MS
- Verification status
- VERIFIED
Annotations 2
Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.
Related records
Same batch — lot QYB-2512-A4980 n=9
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041449 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.13 | 4.40 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041450 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.12 | 4.88 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041451 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.30 | 4.59 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041452 | QYB-2512-A4980 | PeptideMeter | 2026-Q1 | 99.01 | 4.14 | 92.6 | Buyer-sourced | 0 | PASS |
| AX-2026-041453 | QYB-2512-A4980 | Nordanalyt | 2026-Q1 | 99.41 | 4.07 | 89.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041454 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.32 | 4.37 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041455 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.17 | 4.41 | 97.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041457 | QYB-2512-A4980 | Janoshik | 2026-Q1 | 99.27 | 4.53 | 103.1 | Buyer-sourced | 0 | PASS |
Cross-sections
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042265 | TFC | TFC-2605-U1300 | PeptideMeter | 2026-Q3 | 99.52 | 6.31 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042236 | TFC | TFC-2608-S9940 | Nordanalyt | 2026-Q3 | 98.64 | 1.80 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042264 | TFC | TFC-2605-U1300 | Nordanalyt | 2026-Q3 | 99.62 | 6.67 | 89.5 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042237 | TFC | TFC-2608-S9940 | Janoshik | 2026-Q3 | 98.71 | 1.73 | 93.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042266 | TFC | TFC-2605-U1300 | Janoshik | 2026-Q3 | 99.38 | 6.55 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042235 | TFC | TFC-2608-S9940 | Kestrel | 2026-Q3 | 98.59 | 2.01 | 102.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042240 | TFC | TFC-2608-S9940 | Janoshik | 2026-Q3 | 98.50 | 1.95 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042239 | TFC | TFC-2608-S9940 | Janoshik | 2026-Q3 | 98.38 | 2.57 | 96.0 | Buyer-sourced | 0 | PASS |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041471 | PT-141 (Bremelanotide) | QYB-2607-L4875 | Janoshik | 2026-Q3 | 99.72 | 3.75 | 101.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041377 | Ipamorelin | QYB-2605-H3558 | Nordanalyt | 2026-Q3 | 99.93 | 4.35 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041427 | Retatrutide | QYB-2604-B4920 | PeptideMeter | 2026-Q3 | 97.93 | 2.45 | 101.7 | Buyer-sourced | 0 | PASS |
| AX-2026-041428 | Retatrutide | QYB-2604-B4920 | Janoshik | 2026-Q3 | 98.35 | 3.20 | — | Laboratory-retained | 0 | PASS |
| AX-2026-041473 | PT-141 (Bremelanotide) | QYB-2607-L4875 | PeptideMeter | 2026-Q3 | 99.58 | 3.74 | 94.4 | Buyer-sourced | 0 | PASS |
| AX-2026-041472 | PT-141 (Bremelanotide) | QYB-2607-L4875 | PeptideMeter | 2026-Q3 | 99.93 | 3.94 | — | Buyer-sourced | 0 | PASS |
| AX-2026-041429 | Retatrutide | QYB-2604-B4920 | Medutest | 2026-Q3 | 98.53 | 2.69 | 99.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041431 | Retatrutide | QYB-2604-B4920 | Janoshik | 2026-Q3 | 98.63 | 2.32 | 94.2 | Buyer-sourced | 0 | PASS |